Langue: anglais
Edité par New York Academy of Sciences, New York, 1986
ISBN 10 : 0897663322 ISBN 13 : 9780897663328
Vendeur : John M. Gram, Port Huron, MI, Etats-Unis
Edition originale
EUR 8,74
Quantité disponible : 1 disponible(s)
Ajouter au panierSoft cover. Etat : Very Good. 1st Edition. mild shop wear, otherwise clean and sound, new remainder, no creasing, octavo paperback, 408 pages.
Langue: anglais
Edité par New York Academy of Sciences, 1986
ISBN 10 : 0897663314 ISBN 13 : 9780897663311
Vendeur : Book Bungalow, Edinburgh, Royaume-Uni
EUR 9,46
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Very Good. Tight clean hardback, name on fly, not a library book.
Langue: anglais
Edité par New York Academy of Sciences, USA, 1986
ISBN 10 : 0897663314 ISBN 13 : 9780897663311
Vendeur : The Book Exchange, Macclesfield, CHESH, Royaume-Uni
EUR 6,96
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Good. No Jacket. 0897663314. Blue cloth hardcover, from closed pharmaceutical company library. 408 pages, index, illustrated with charts, tables and diagrams. Contents paper clip marks on front endpapers clean, tight and bright. Book.
Langue: allemand
Edité par Berlin, Heidelberg, New York : Springer, 1975
ISBN 10 : 3540070354 ISBN 13 : 9783540070351
Vendeur : books4less (Versandantiquariat Petra Gros GmbH & Co. KG), Welling, Allemagne
EUR 11,95
Quantité disponible : 1 disponible(s)
Ajouter au panierBroschiert. Etat : Gut. XV, 182 S. Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.). Schnitt und Einband sind etwas staubschmutzig; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Sprache: Deutsch Gewicht in Gramm: 400.
Langue: anglais
Edité par New York Academy of Sciences, NY, 1986
ISBN 10 : 0897663322 ISBN 13 : 9780897663328
Vendeur : Tiber Books, Cockeysville, MD, Etats-Unis
EUR 55,09
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Very Good. . . . . 8vo, paperback. Vg condition. Exterior faintly rubbed, contents bright & clean, binding tight. 408 p. Papers presented at a conference held by the Engineering Foundation and the Society for Analytical Cytology on December 7-12, 1983, at the Cloister, Sea Island, Georgia.
Langue: anglais
Edité par Berlin/ Heidelberg/ New York/ Tokyo, Springer, 1985
ISBN 10 : 0387153764 ISBN 13 : 9780387153766
Vendeur : Antiquariat Hans-Jürgen Ketz, Münster, NRW, Allemagne
EUR 45
Quantité disponible : 1 disponible(s)
Ajouter au panierVIII, 141 Seiten. 49 graphische Darstellungen und 56 Tabellen. Großoktav (24x16 cm) Orig.Karton. ** Gutes, sauberes Exemplar. Mit persönlicher Widmung des Autors J. Schumann.
Vendeur : BGV Books LLC, Murray, KY, Etats-Unis
EUR 99,18
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Good. Exact ISBN match. Immediate shipping. No funny business.
Langue: anglais
Edité par Springer-Verlag Publishing, 2014
ISBN 10 : 1493913921 ISBN 13 : 9781493913923
Vendeur : Salish Sea Books, Bellingham, WA, Etats-Unis
EUR 100,52
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Very Good. Very Good++; Hardcover; Close to new condition; Covers are still glossy with "straight" edge-corners; Unblemished textblock edges; The endpapers and all text pages are bright and unmarked; Binding is tight with a straight spine; This book will be stored and delivered in a sturdy cardboard box with foam padding; Medium Format (8.5" - 9.75" tall); Blue, purple, and orange covers with title in white lettering; 2014, Springer-Verlag Publishing; 826 pages; "Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)," by Michael Andreeff.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 162,73
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Langue: anglais
Edité par Springer-Verlag New York Inc., New York, 2014
ISBN 10 : 1493913921 ISBN 13 : 9781493913923
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
EUR 187,71
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : new. Hardcover. This book provides an unprecedented overview of "Targeted Therapies" for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make "leukemia history" in the near future. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Vendeur : moluna, Greven, Allemagne
EUR 136,16
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Vendeur : moluna, Greven, Allemagne
EUR 136,16
Quantité disponible : Plus de 20 disponibles
Ajouter au panierGebunden. Etat : New.
Vendeur : preigu, Osnabrück, Allemagne
EUR 141,20
Quantité disponible : 5 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Targeted Therapy of Acute Myeloid Leukemia | Michael Andreeff | Taschenbuch | xix | Englisch | 2016 | Springer US | EAN 9781493939893 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
EUR 202,01
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New.
EUR 220,02
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 219,40
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. 1st edition NO-PA03JAN2015-KAP.
EUR 229,67
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Langue: anglais
Edité par Springer New York, Springer US, 2014
ISBN 10 : 1493913921 ISBN 13 : 9781493913923
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 166,41
Quantité disponible : 1 disponible(s)
Ajouter au panierBuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.
Vendeur : Little Moon Books, San Francisco, CA, Etats-Unis
Edition originale
EUR 236,06
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Very Good. 1st Edition. Hardcover, 455 pages, 1999. First Edition . A Nearly Very Good copy. Book has moderate wear, crease or crimp to a few pages. Text appears clean.
Langue: anglais
Edité par Springer New York, Springer US, 2016
ISBN 10 : 1493939890 ISBN 13 : 9781493939893
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 170,64
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.
EUR 227,06
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 242,68
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. 826.
Vendeur : Revaluation Books, Exeter, Royaume-Uni
EUR 239,63
Quantité disponible : 2 disponible(s)
Ajouter au panierHardcover. Etat : Brand New. 1st edition. 826 pages. 9.25x6.25x2.00 inches. In Stock.
Langue: anglais
Edité par Springer, Berlin, Springer, 2016
ISBN 10 : 3662500523 ISBN 13 : 9783662500521
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 206,10
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - How Do We Treat Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth reg- lation, and cellular functions has led to novel therapeutic paradigms. Targeted trea- ment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. Patients are increasingly well educated as web-based information on diagnostic and therapeutic options as well as quality ma- agement and tumor outcome data are readily available. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality ma- agement, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of p- tients with solid tumors and hematological neoplasms at the Freiburg University Med- cal Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of 'Good Clinical Pra- tice.' Tese processes (e.g., detailed protocols for chemotherapy application, treatment fowcharts, clinical pathways) are continuously tested and validated in clinical practice.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
EUR 256,96
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Like New. Like New. book.
Langue: anglais
Edité par Wiley & Sons, Incorporated, John, 1999
ISBN 10 : 0471013455 ISBN 13 : 9780471013457
Vendeur : Better World Books, Mishawaka, IN, Etats-Unis
EUR 303,05
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Very Good. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
EUR 524,63
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Langue: allemand
Edité par Berlin, Heidelberg, New York : Springer, 1975
ISBN 10 : 3540070354 ISBN 13 : 9783540070351
Vendeur : NEPO UG, Rüsselsheim am Main, Allemagne
EUR 45,49
Quantité disponible : 1 disponible(s)
Ajouter au panierBibliothekseinband. Etat : Gut. XV, 182 S. : 97 Ill. u. graph. Darst., , 24 cm Beiträge teilw. dt., teilw. engl. aus einer wissenschaftlichen Bibliothek Sprache: Deutsch Gewicht in Gramm: 550.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 126,26
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Langue: anglais
Edité par Springer New York Sep 2016, 2016
ISBN 10 : 1493939890 ISBN 13 : 9781493939893
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 160,49
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future. 848 pp. Englisch.